Summit
Biomedical Imaging
Targeted Cancer
Diagnostics
Rapid, Point-of-Care Cancer Detection
About Us
OUR STORY
OUR VISION
Summit Biomedical Imaging is dedicated to improving early cancer detection using fluorescent targeted diagnostic agents. Our first target is oral cancer detection.
Our point-of-care oral diagnostic technology is fast, non-invasive, and extremely accurate. We empower clinicians to improve patient outcomes via early intervention.
69%
Of oral cancers are detected when metastatic
83%
5-year survival rate for localized disease
38%
5-year survival rate for metastatic oral cancer that has moved beyond the local tissue
Technology
Our proprietary technology is a fluorescent small molecule, PARPi-FL, that detects overexpression of PARP, a DNA repair enzyme, which is common in many cancers. Thus, our technology specifically targets oral cancer, enabling earlier, more accurate detection.
Pipeline
Summit Biomedical Imaging is developing targeted diagnostics for multiple cancers.
Management
Andrew Riley, J.D., Ph.D.
CEO & GC
Andrew Riley is the Chief Executive Officer and General Counsel of Summit Biomedical Imaging. Dr. Riley has more than ten years of experience working with pharmaceutical clients at a major, full-service law firm as a registered patent attorney. Prior to working as a patent attorney, Dr. Riley was a Senior Research Chemist at a major petrochemical company. Dr. Riley earned a J.D. from Fordham University School of Law and a Ph.D. from the University of California at Los Angeles.
Christian Brand, Ph.D.
CSO & Co-Founder
Christian Brand is a founding member and the Chief Scientific Officer of Summit Biomedical Imaging. After earning his Ph.D. from Georg-August-Universität Göttingen, Dr. Brand worked as a Post-Doctoral Research Scholar and Research Associate specializing in molecular imaging at Memorial Sloan Kettering Cancer Center. At Memorial Sloan Kettering Cancer Center, Dr. Brand developed and translated next-generation targeted cancer diagnostics and was involved in the submission of several successful IND applications to the FDA.
Advisors
![RMU head shot[1].jpg](https://static.wixstatic.com/media/b6ccf0_c579211added45d1b71c1ee1e2080ef8~mv2.jpg/v1/crop/x_15,y_0,w_168,h_245/fill/w_170,h_248,al_c,lg_1,q_80,enc_auto/RMU%20head%20shot%5B1%5D.jpg)
Robert M. Unnold, M.B.A.
Executive Director
Bob Unnold is an entrepreneur with over 35 years of experience in business development. Bob has founded several successful companies and held a variety of management positions in those companies. Bob’s experience includes navigating the challenges faced by early-stage startups through acquisition or going public. Bob earned an M.B.A. from St. John’s University.